All MIT articles
-
NewsDNA particles that mimic viruses hold promise as vaccines
Using a DNA-based scaffold carrying viral proteins, researchers created a vaccine that provokes a strong antibody response against SARS-CoV-2.
-
NewsResearchers use AI to identify a new class of antibiotic candidates
Using deep learning, researchers have discovered a class of compounds that can kill methicillin-resistant Staphylococcus aureus (MRSA) grown in a lab dish and in two mouse models of MRSA infection.
-
NewsMicrobes could help reduce the need for chemical fertilizers
Chemical engineers have developed a coating that protects nitrogen-fixing bacteria from heat and humidity, which could allow them to be deployed for large-scale agricultural use.
-
NewsGermicidal UV lights could be producing indoor air pollutants, study finds
While useful for killing pathogens including SARS-CoV-2, the lights may cause unwanted chemical reactions and should be used with ventilation, researchers say.
-
News Targeting a coronavirus ion channel could yield new Covid-19 drugs
Chemists discover the structures of open and closed states of the channel, which could help the development of antiviral drugs to reduce inflammation.
-
NewsResearchers using synthetic microbiomes to protect aquatic communities from bacteria
Scientists have been awarded a grant to create synthetic microbiomes – communities of microorganisms – that will better protect aquatic environments from bacteria.
-
NewsAI-found drug may combat drug-resistant infections
Scietntists used a machine-learning algorithm to identify a compound that kills Acinetobacter baumannii, a bacterium that lurks in many hospital settings.
-
NewsScientists discover a new way of sharing genetic information in a common ocean microbe
<i>Prochlorococcus</i>, the world’s most abundant photosynthetic organism, reveals a gene-transfer mechanism that may be key to its abundance and diversity.
-
NewsGene-delivering viruses cross into brain in step toward gene therapy for neurological diseases
A family of adeno-associated viruses (AAVs) has been developed that are capable of delivering gene therapies to the brain, a particularly challenging target tissue.
